Dashboard
Manage Tickers

IPSC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

century-therapeuics-appoints-brent-pfeiffenberger-as-chairman
Century Therapeuics Appoints Brent Pfeiffe...
08/14/2025 20:59:57

century-therapeutics-q2-eps-038-misses-037-estimate
Century Therapeutics Q2 EPS $(0.38) Misses...
08/14/2025 20:26:03

century-therapeutics-files-for-mixed-shelf-offering-of-up-to-200m
Century Therapeutics Files For Mixed Shelf...
07/10/2025 20:58:30

- SEC Filing

chardan-capital-maintains-buy-on-century-therapeutics-lowers-price-target-to-6
Chardan Capital Maintains Buy on Century T...
05/16/2025 22:33:52

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

century-therapeutics-q1-eps-089-beats-016-estimate-sales-10916m-beat-4955m-estimate
Century Therapeutics Q1 EPS $0.89 Beats $0...
05/15/2025 20:16:26

Century Therapeutics (NASDAQ:IPSC) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/16/2025 12:07:22

hc-wainwright--co-maintains-buy-on-century-therapeutics-lowers-price-target-to-2
HC Wainwright & Co. Maintains Buy on Centu...
04/03/2025 10:59:41

HC Wainwright & Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/28/2025 21:05:46

guggenheim-reiterates-buy-on-century-therapeuticsto-buy
Guggenheim Reiterates Buy on Century Thera...
03/28/2025 14:43:23

Guggenheim analyst Kelsey Goodwin reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.

carnival-to-rally-around-48-here-are-10-top-analyst-forecasts-for-monday
Carnival To Rally Around 48%? Here Are 10 ...
03/24/2025 12:48:18

chardan-capital-maintains-buy-on-century-therapeutics-lowers-price-target-to-7
Chardan Capital Maintains Buy on Century T...
03/24/2025 12:07:01

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

demystifying-century-therapeutics-insights-from-4-analyst-reviews
Demystifying Century Therapeutics: Insight...
03/21/2025 14:01:08

guggenheim-maintains-buy-on-century-therapeutics-lowers-price-target-to-5
Guggenheim Maintains Buy on Century Therap...
03/21/2025 13:55:07

Guggenheim analyst Kelsey Goodwin maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target from $...

piper-sandler-maintains-overweight-on-century-therapeutics-lowers-price-target-to-2
Piper Sandler Maintains Overweight on Cent...
03/20/2025 16:37:49

Piper Sandler analyst Edward Tenthoff maintains Century Therapeutics (NASDAQ:IPSC) with a Overweight and lowers the price ta...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 21:06:24

century-therapeutics-fy24-eps-161-up-from-230-yoy-revenue-659m-up-from-224m-yoy
Century Therapeutics FY24 EPS $(1.61) Up F...
03/19/2025 20:04:23

century-therapeutics-announces-preclinical-pipeline-re-prioritization-to-focus-on-four-potentially-transformative-programs-to-advance-toward-clinic-led-by-cnty-308-in-b-cell-mediated-autoimmune-diseases-and-malignancies-new-concentrated-clinical-focus-for-cnty-101-based-on-unique-profile-with-transformational-potential-in-autoimmune-disease-data-anticipated-in-2025
Century Therapeutics Announces Preclinical...
03/19/2025 20:03:37

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CN...

century-therapeutics-shares-halted-news-pending
Century Therapeutics Shares Halted, News P...
03/19/2025 20:02:22

century-therapeutics-receives-nasdaq-notice-for-bid-price-deficiency
Century Therapeutics Receives Nasdaq Notic...
02/28/2025 21:22:15

- SEC Filing

guggenheim-reiterates-buy-on-century-therapeuticsto-buy
Guggenheim Reiterates Buy on Century Thera...
01/22/2025 15:49:33

Guggenheim analyst Michael Schmidt reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION